Shandong Keyuan Pharmaceutical Co., Ltd.

SZSE:301281 Stock Report

Market Cap: CN¥3.8b

Shandong Keyuan Pharmaceutical Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Jianwei Wang

Chief executive officer

CN¥427.1k

Total compensation

CEO salary percentagen/a
CEO tenure2.1yrs
CEO ownershipn/a
Management average tenureno data
Board average tenureless than a year

Recent management updates

Recent updates

More Unpleasant Surprises Could Be In Store For Shandong Keyuan Pharmaceutical Co., Ltd.'s (SZSE:301281) Shares After Tumbling 27%

Apr 18
More Unpleasant Surprises Could Be In Store For Shandong Keyuan Pharmaceutical Co., Ltd.'s (SZSE:301281) Shares After Tumbling 27%

Shandong Keyuan Pharmaceutical's (SZSE:301281) Weak Earnings May Only Reveal A Part Of The Whole Picture

Apr 08
Shandong Keyuan Pharmaceutical's (SZSE:301281) Weak Earnings May Only Reveal A Part Of The Whole Picture

CEO

Jianwei Wang (40 yo)

2.1yrs

Tenure

CN¥427,100

Compensation

Board Members

NamePositionTenureCompensationOwnership
Yi Ma
Non-Employee Supervisorless than a yearno datano data
Bin Wu
Non-Independent Directorless than a yearCN¥17.00kno data
Haiying Zheng
Independent Director5.6yrsCN¥100.00kno data
Yongbo Ge
Independent Director5.6yrsCN¥100.00kno data
Kang Yuan
Independent Director3.8yrsCN¥100.00kno data
Xiaohong Zou
Non-Independent Vice Chairman9.2yrsno datano data
Hongsheng Jiang
Non-Independent Chairman of the Board1.5yrsno datano data
Huiyu Dai
Independent Directorless than a yearno datano data
Dawei Zeng
Non-Employee Supervisorless than a yearno datano data
Yuankun Gao
Non-Independent Directorless than a yearno datano data
Lina Jin
Independent Directorless than a yearno datano data

1.0yrs

Average Tenure

58.5yo

Average Age

Experienced Board: 301281's board of directors are not considered experienced ( 1 years average tenure), which suggests a new board.